Antibacterial spectrum of an antibiotic and clinical categorization;Spectre d'activité antibactérien d'un antibiotique et catégorisation clinique

Pathologie Biologie

Volumn 56, Issue 5, 2008, Pages 300-304

  Cavallo, J D ^a,b   Merens A ^a,b  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b Hôpital Inter Armées du Val de Grâce   (France)

Author keywords

Antibiotic; Antibiotic spectrum; Clinical categorisation; Minimum inhibitory concentration

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; EUROPE; FRANCE; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

EID: 47049123855     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.09.022     Document Type: Article

References (7)

1. European Committee for Antimicrobial Susceptibility Testing. Determination of antimicrobial susceptibility test breakpoints. Clin Microbiol Infect 6 (2000) 570-572
2. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Product (CPMP). Note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections. London, 22 april 2004. Téléchargeable sur http://emea.eu.int.
3. Leegard T.M., Caugant D.A., Froholm L.O., and Hoiby E.A. Apparent differences in antimicrobial susceptibility as a consequence of national guidelines. Clin Microbiol Infect 6 (2000) 290-293
4. Khalmeter G., Brown D.F.J., Goldstein F.W., MacGowan A., Mouton J., Osterlund A., et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 52 (2003) 145-148
5. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. M100-S15. Clinical and Laboratory Standards Institute. Wayne. Pa.
6. Lamy B., Carret G., Flandrois J.P., and Delignette-Muller M.L. How does susceptibility prevalence impact on the performance of disk diffusion susceptibility testing?. Diag Microbiol Infect Dis 49 (2004) 131-139
7. Jacobs M.R., Koeth L.M., and Appelbaum P.C. Use of appropriate breakpoints in antimicrobial surveillance studies. Clin Infect Dis 35 (2002) 1446-1448